NIGP 26936: Diagnostic Agents

NIGP 26936 Diagnostic Agents, an Item code, encompasses emergency response pharmaceuticals and clinical laboratory supplies that state and local governments procure for health departments, emergency services, and academic medical centers. Recent solicitations show state and local buyers acquiring naloxone for opioid overdose response, drug deactivation systems, and comprehensive biotech research and clinical diagnostic product catalogs including antibodies, immunoassay kits, molecular biology reagents, chromatography and flow cytometry systems, and hematology products. Issuing bodies include county health departments and university health science centers. Seminole County, Florida and the University of Texas Health Science Center at San Antonio (UTHSA) both posted opportunities under this code in 2026, representing the mix of municipal health infrastructure and academic research procurement that drives activity here.

Seminole County posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, Florida; the bid deadline was July 26, 2026. UTHSA released RFP 745-26-P19 on May 7, 2026, for an open-ended biotech research and clinical diagnostics supplier catalog covering approximately 8,768 line items ordered in the prior year, with proposals due June 4, 2026. Florida and Texas show recent activity under the code. The Seminole County contract carries a two-year initial term with one-year renewal option and includes potential FEMA funding with associated federal compliance requirements. The UTHSA contract spans one year with up to three one-year renewals and mandates HUB subcontracting plan submission, Jaggaer e-procurement catalog integration, TX-RAMP Level II certification, and comprehensive insurance including $10 million cyber liability coverage.